Kiora Pharmaceuticals (KPRX) Accumulated Depreciation & Amortization (2016 - 2024)
Kiora Pharmaceuticals (KPRX) has disclosed Accumulated Depreciation & Amortization for 9 consecutive years, with $19205.0 as the latest value for Q4 2024.
- For the quarter ending Q4 2024, Accumulated Depreciation & Amortization fell 62.92% year-over-year to $19205.0, compared with a TTM value of $19205.0 through Dec 2024, down 62.92%, and an annual FY2024 reading of $19205.0, down 62.92% over the prior year.
- Accumulated Depreciation & Amortization was $19205.0 for Q4 2024 at Kiora Pharmaceuticals, down from $51798.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $108378.0 in Q3 2021 and bottomed at $19205.0 in Q4 2024.
- Average Accumulated Depreciation & Amortization over 4 years is $77631.7, with a median of $87128.0 recorded in 2020.
- The sharpest move saw Accumulated Depreciation & Amortization skyrocketed 546.74% in 2020, then tumbled 62.92% in 2024.
- Year by year, Accumulated Depreciation & Amortization stood at $92974.0 in 2020, then tumbled by 51.28% to $45296.0 in 2021, then grew by 14.35% to $51798.0 in 2023, then crashed by 62.92% to $19205.0 in 2024.
- Business Quant data shows Accumulated Depreciation & Amortization for KPRX at $19205.0 in Q4 2024, $51798.0 in Q4 2023, and $45296.0 in Q4 2021.